期刊文献+

以消化道出血或腹腔积液为首发症状的骨髓增殖性肿瘤合并门静脉血栓形成或门静脉海绵样变性6例诊治分析

下载PDF
导出
摘要 造成门静脉血流梗阻的常见原因包括门静脉血栓形成(portal vein thrombosis,PVT)、腹部肿瘤侵犯或压迫门静脉,临床上以PVT最为常见[1]。PVT的发病因素包括血管壁损伤、血流瘀滞和血液高凝状态,其发生、发展是一个多因素参与的过程,涉及局部因素和全身血栓前状态的协同作用[1],诊治具有一定的复杂性,若未及时诊治,可导致肠系膜缺血、门静脉海绵样变性(cavernous transformation of portal vein,CTPV)和门静脉高压症等。
出处 《血管与腔内血管外科杂志》 2023年第3期372-375,共4页 Journal of Vascular and Endovascular Surgery
基金 河南省科技攻关项目(222102310014)。
  • 相关文献

参考文献3

二级参考文献12

  • 1TEFFERI A,THIELE J, VARDIMAN J W. The 2008 World Health Organization classification system for myeloprolifera- rive neoplasma[ J ]. Cancer ,2009,115 ( 17 ) :3842-3847.
  • 2TEFFERIA A,THIELE J, ORAZI A, et al. Proposals and ra- tionale for revision of the World. Health Organization diag- nostic. Criteria for polycythemia vera, essential thrombocy- themia, and primary myelofibrosis: Recommendations from an ad hoc internation expert panel [ J ]. Blood, 2007,110 : 1092-1097.
  • 3BAXTER, EJ, SCOTF LM, CAMPBEL DJ, et al. Acguired mutation of the tyrosinek kinase JAK2 in human myeloprolif- erative disorders [ J ]. Lancet,2005,365 : 1054-1061.
  • 4TEFFERI A, VARDIMAN JW. Classification and diagnosis of myeloprolifentive neoplasma:The 2008 world Health Or-ganization criteria and point of care diagnostic algorithms [ J]. Leukemia ,2008,22 : 14-22.
  • 5VANNUECHI AM, ANATONIOLI E, GUGLIELMELLI P, et al. Chinical profile of homozygous JAK2V617F mutation in patients with polycythemia vera of essential thrombotythemia [J ]. Blood,2005,110 ( 3 ): 840- 846.
  • 6PAPADAKIS E, HOFFMAN R, BRENNTER B. Thrombohe- morrhagic complications of myeloproliferative disarders [ J ]. Blood Rev ,2010,24:227-232.
  • 7SUN T, ZHANG L. Thrombosis in myeloproliferative neo- plasma with JAK2V617F mutation [ J]. Clin Appl Thromb Hemost,2012,23. [Epub ahead of printl.
  • 8VANNUVCHI AM, ANTONIOLI E, GUGLIELMELLI P, et al. Chinical profile of homezygous JAK2V617F mutation in patients with polycythemia vera or essential thrombocythemia [ J ]. Blood,2007,110 ( 3 ) .. 800- 846.
  • 9Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia [J]. Blood, 2016, 127 (20): 2391-2405.
  • 10Vardiman JW, ~Aele J, Arber DA, et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes[J]. Blood, 2009, 114(5): 937-951.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部